Krishna Vaddi - CEO, Director at Prelude Therapeutics Inc

Insider Transactions and Holdings

Entity Type: Individual
Role: CEO, Director
Issuer Symbol: PRLD on Nasdaq
All Insider Reports: All Insider Reports

Krishna Vaddi - trading volume in the past year for Prelude Therapeutics Inc

	Shares	%	Avg Price	Total $
Buys	+832,021	100%	$0.6987	+$581,371
Sells
Net	+832,021	100%		+$581,371

Holdings reported by Krishna Vaddi for Prelude Therapeutics Inc

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	1,999,296	$1,384,512	$0.6925	25 Mar 2025	Direct
Common Stock	551,776	$382,105	$0.6925	25 Mar 2025	By Trust
Common Stock	142,553	$98,718	$0.6925	25 Mar 2025	Indirect
Employee Stock Option (right to buy)	496,000			04 Feb 2025	Direct	Common Stock

Transactions reported by Krishna Vaddi for Prelude Therapeutics Inc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.